Loading, Please Wait...

CST: 11/11/2019 16:46:15   

Marrone Bio Innovations to Report Third Quarter 2019 Results on Tuesday, November 12th at 4:30 p.m. Eastern Time

7 Days ago

DAVIS, Calif., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, will release financial results for the third quarter ended September 30, 2019, after market close on Tuesday, November 12, 2019.

Management will host an investor conference call at 1:30 p.m. PST (4:30 p.m. EST) on November 12, 2019, to discuss Marrone Bio Innovations’ third quarter 2019 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information:

Q3 2019 Conference Call and Webcast
Date: Tuesday, November 12, 2019
Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern time)
U.S. Dial-in: 1-866-575-6539
International Dial-in: 1-323-794-2551
Conference ID: 8693394
Webcast: http://public.viavid.com/index.php?id=136977

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through December 12, 2019. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally. Please use the replay pin number 8693394. A webcast will also be available for 30 days on the IR section of the Marrone Bio Innovations website or by clicking here: MBII Q3 2019 Webcast.

About Marrone Bio Innovations
Marrone Bio Innovations Inc. (NASDAQ: MBII) is a growth-oriented company leading the movement to more a sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment that help customers operate more sustainably while increasing their return on investment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies and natural product chemistry to rapidly develop seven product lines. Supported by a robust portfolio of over 400 issued and pending patents, MBI’s currently available commercial products are Regalia®, Stargus®, Grandevo®, Venerate®, Majestene®, Haven® and Amplitude®, Zelto® Jet-Oxide® and Jet-Ag® and Zequanox®, with a breakthrough bioherbicide and biofumigant in the Company’s product pipeline. MBI’s Finland-based subsidiary Pro Farm® employs a proprietary technology derived from wood waste to stimulate plant growth and improve plant health, resulting in improved yields and crop quality. Products include Foramin®, UBP-110™, LumiBio Valta™, LumiBio Kelta™.

Learn more about Marrone Bio Innovations at www.marronebio.com. We also use our investor relations website, https://investors.marronebio.com, as well as our corporate Twitter account, @Marronebio, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Follow us on social media: TwitterLinkedIn and Instagram.

Marrone Bio Innovations Contact:
Pam Marrone, CEO and Founder
Telephone: +1 (530) 750-2800
Email: Info@marronebio.com

Investor Relations Contact:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
MBII@mzgroup.us
www.mzgroup.us

Is your business listed correctly on America’s largest city directory network of 1,000 portals?